Ibruxen 140mg capsule

Description

Ibruxen 140 mg 120 capsule is a prescription medicine used for the oral treatment of blood cancers using ibrutinib.

This is a targeted cancer medicine designed to block abnormal signaling proteins responsible for the survival and replication of cancer cells.

This drug binds to BTK and inhibits their proliferation and migration Ibruxen 140 mg.

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Ibrutinib Ibruxen 140MG PRICE IN PAKISTAN  is used for the treatment of adult patients with Chronic Lymphocytic Leukemia (CLL)/small lymphocytic lymphoma (SLL).

The acalabrutinib (Calquence) and zanubrutinib (Brukinsa) are highly potent drugs that effectively act on second-generation BTK inhibitors. This treatment is highly efficient in the treatment of Blood Cancers like Chronic.

Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL). Moreover, the drugs have an excellent safety profile compared to first-generation ibrutinib (Imbruvica).

First-line Treatment Options for CLL include continuous treatments using either ibrutinib, zanubrutinib, or acalabrutinib-based regimens, or fixed duration treatment including the combination of BCL2 inhibitor venetoclax with obinutuzumab or combinations of BTK inhibitors ibrutinib or acalabrutinib (plus or minus obinutuzumab).

Ibrex 120mg Tablet is an antiallergic medication that is used in treating allergies like allergic rhinitis and chronic idiopathic urticaria. The medicine provides relief in symptoms like sneezing, running of nose, nasal congestion, itchiness, watering of eyes, and hives.

About fifty percent of individuals suffering from chronic lymphocytic leukemia (CLL) survive for more than ten years.